Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CPC1 Hanoi Pharmaceutical Joint Stock Company is a prominent high-tech pharmaceutical manufacturer based in Vietnam, recognized for its leadership in advanced drug delivery technologies. The company was the first in Vietnam to implement Blow-Fill-Seal (BFS) technology, enabling the production of sterile, preservative-free plastic ampoules for respiratory and ophthalmic use. Their diverse portfolio encompasses small molecule generics, therapeutic probiotics, and aerosol medications across therapeutic areas such as pediatrics, gastroenterology, and ophthalmology. Operating under strict GMP-WHO standards, CPC1 Hanoi serves both the domestic Vietnamese market and an expanding international footprint. The company is committed to R&D, focusing on complex formulations and innovative delivery systems to improve patient compliance and treatment efficacy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CPC1 Hanoi.